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Abstract
Background: Traumatic brain injury (TBI) is a major cause of death and disability. Neuroinflammation contributes to
acute damage after TBI and modulates long-term evolution of degenerative and regenerative responses to injury.
The aim of the present study was to evaluate the relationship of microglia activation to trauma severity, brain
energy metabolism, and cellular reactions to injury in a mouse closed head injury model using combined in vivo
PET imaging, ex vivo autoradiography, and immunohistochemistry.
Methods: A weight-drop closed head injury model was used to produce a mixed diffuse and focal TBI or a purely
diffuse mild TBI (mTBI) in C57BL6 mice. Lesion severity was determined by evaluating histological damage and
functional outcome using a standardized neuroscore (NSS), gliosis, and axonal injury by immunohistochemistry.
Repeated intra-individual in vivo μPET imaging with the specific 18-kDa translocator protein (TSPO) radioligand
[18F]DPA-714 was performed on day 1, 7, and 16 and [18F]FDG-μPET imaging for energy metabolism on days 2–5
after trauma using freshly synthesized radiotracers. Immediately after [18F]DPA-714-μPET imaging on days 7 and 16,
cellular identity of the [18F]DPA-714 uptake was confirmed by exposing freshly cut cryosections to film
autoradiography and successive immunostaining with antibodies against the microglia/macrophage marker IBA-1.
Results: Functional outcome correlated with focal brain lesions, gliosis, and axonal injury. [18F]DPA-714-μPET
showed increased radiotracer uptake in focal brain lesions on days 7 and 16 after TBI and correlated with reduced
cerebral [18F]FDG uptake on days 2–5, with functional outcome and number of IBA-1 positive cells on day 7. In
autoradiography, [18F]DPA-714 uptake co-localized with areas of IBA1-positive staining and correlated strongly with
both NSS and the number of IBA1-positive cells, gliosis, and axonal injury. After mTBI, numbers of IBA-1 positive
cells with microglial morphology increased in both brain hemispheres; however, uptake of [18F]DPA-714 was not
increased in autoradiography or in μPET imaging.
Conclusions: [18F]DPA-714 uptake in μPET/autoradiography correlates with trauma severity, brain metabolic deficits,
and microglia activation after closed head TBI.
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Background
Traumatic brain injury (TBI) due to falls or accidents in
traffic and during sport activities is the leading cause of
disability and death among young adults and children in
Europe and the USA [1, 2]. Furthermore, traumatic in-
sults to the brain due to falls have become an increasing
health problem in the elderly [2, 3]. Even though im-
proved emergency and hospital care have reduced the
acute mortality of TBI, surviving patients often live with
severe disabilities and develop progressive brain damage
or dementia of unknown origin [3]. Neuroinflammation
is a key event that contributes to chronic neurodegener-
ation and demyelination, prevents regeneration, and
causes functional deficits after TBI [4, 5]. As the inflam-
matory responses after TBI are complex and probably
reflect the heterogeneity of injury mechanism and co-
morbidities in the TBI population [3–5], a better
characterization of the spatial and temporal evolution of
inflammation by repeated intra-individual monitoring is
needed for the development of targeted therapies. In this
context, repeated in vivo positron emission tomography
(PET) imaging of neuroinflammation represents a
powerful tool and in combination with autoradiography
enables resolution at the cellular level [5–11].
Microglia, the brain macrophages, are the first line of
defense against brain injuries. In TBI, resident microglia
are rapidly mobilized to the injury site, where they con-
tribute to acute damage and modulate the long-term evo-
lution of degenerative and regenerative responses to injury
[4, 8, 12, 13]. Therefore, microglial cell-surface and mito-
chondrial receptors have been used as specific targets in
the development of diagnostic biomarkers of neuroinflam-
mation. One of these microglial targets is the 18-kDa
translocator protein TSPO, a protein of the outer mito-
chondrial membrane that is specifically upregulated in ac-
tivated microglia in injured brain and in neurodegenerative
disease associated with neuroinflammation [8, 14].
The radiotracer [11C]PK11195 has been most commonly
used as radiolabeled TSPO ligand for in vivo PET imaging
or autoradiography [6, 14–16]. However, the major draw-
back of PET with [11C]PK11195 is the high unspecific ac-
cumulation of [11C]PK11195 in healthy brain resulting in a
poor signal to noise ratio [16]. Therefore, efforts have been
undertaken to develop a more specific radiotracer than
[11C]PK11195 for molecular imaging of TSPO by PET.
Among the recently developed radiotracers for targeting
TSPO, the radiofluorinated agent N,N-diethyl-2-(2-(4-(2-
[18F]fluoroethoxy)phenyl)-5,7-dimethyl-pyrazolo[1,5-α]
pyrimidin-3-yl)acetamide ([18F]DPA-714) exhibited super-
ior binding affinities, low lipophilicity, and an improved
target-to-background binding ratio in previous compara-
tive investigations [16, 17]. Moreover, the longer physical
half life (t½) of 18F of 110 min, compared with t½ =
20 min for 11C makes [18F]DPA-714 highly suitable for
PET imaging even in facilities without an in-house cyclo-
tron. Due to these advantages, [18F]DPA-714 has been
tested experimentally as an imaging probe for TSPO in
different models [11, 16–18]. In the present study, we
aimed at evaluating microglia activation in a murine
closed head injury model using a combined approach of
in vivo [18F]DPA-714 PET imaging, combined ex vivo
autoradiography, and IBA-1 immunohistochemistry. In
particular, we wanted to determine the relationship of
microglia activation to trauma severity and cellular reac-
tions to injury and correlate TSPO ligand binding to brain
glucose uptake in the first 2–5 days after trauma by 2-
[18F]Fluoro-2-deoxyglucose ([18F]FDG) PET imaging.
Methods
Radiochemistry
All chemicals and solvents were purchased commercially
from Sigma-Aldrich (Deisenhofen, Germany) and Carl
Roth (Karlsruhe, Germany), respectively. If not stated
otherwise, they were used in the synthesis without fur-
ther purification.
[18F]Fluoride for the synthesis of N,N-diethyl-2-(2-(4-(2-
[18F]fluoroethoxy)phenyl)-5,7-dimethyl-pyrazolo[1,5-α]
pyrimidin-3-yl)acetamide ([18F]DPA-714) and [18F]FDG
was produced on the GE-PETtrace cyclotron (General
Electric Medical Systems, Uppsala, Sweden) at the Inter-
disciplinary PET-Centre (IPZ) of the University Hospital
of Würzburg via 18O(p,n)18F reaction by irradiating
3.0 mL of 97 % enriched [18O]H2O with 16.5 MeV pro-
tons. [18F]FDG and [18F]DPA-714 were synthesized using
a GE Fastlab® synthesis module (GE Medical Systems,
Uppsala, Sweden) and the Raytest SynChrom module
(Raytest, Straubenhardt, Germany), respectively as de-
scribed previously [19]. Both radiotracers have been estab-
lished for clinical and preclinical applications.
Animal model
All animal experiments were carried out according to
the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996) and in compliance
with the German animal protection law. Experiments
were approved by the district government of Lower
Franconia (Regierung von Unterfranken AZ: 55.2/
2531.01-53/12). Male 10–15-week-old C57BL/6N mice
were purchased from Charles River (Sulzfeld, Germany)
and maintained in the animal facility of the University of
Würzburg, Department of Neurology. A closed head
traumatic brain injury was produced as previously de-
scribed [20–22] in 43 mice. Briefly, the mice were anes-
thetized and maintained with 2 % isoflurane anesthesia
in 100 % oxygen during the whole procedure. A midline
longitudinal scalp incision was made to expose the skull.
The head was fixed by holding it with two fingers to
Israel et al. Journal of Neuroinflammation  (2016) 13:140 Page 2 of 13
keep the mice in the right position and to allow a slight
movement at the moment of the trauma induction. After
identification of the impact area over the right fronto-
parietal cortex, TBI was induced by a falling weight
(95 g) with a silicone-covered blunt tip onto the skull
from the height of 3 cm (n = 14, 8 classified as mTBI, 6
classified as TBI) to 4 cm (n = 29, 16 classified as mTBI
and 19 classified as TBI). After TBI induction, the mice
shortly received 100 % oxygen. The skull was examined
to preclude fractures and the skin closed. Sham oper-
ation included anesthesia and exposure of the skull but
without weight-drop injury. It was performed in 10 mice.
The neurobehavioral status of the mice was assessed by
the neurological severity score (NSS) [21, 23, 24], a com-
posite score including tasks on motor function, alert-
ness, and physiological behavior, with higher scores
indicating more severe deficit. Functional testing was
performed initially at 1 h after and repeated on days 1
and 7 after weight-drop injury by investigators blinded
to the experimental groups.
Final TBI classification was based on postmortem
evaluation of morphological damage on hematoxylin-
eosin stained sections. The mice were sacrificed by CO2
inhalation, and the brains were quickly removed and im-
mediately frozen in methyl butane on dry ice. Coronal
18 μm-thin sections throughout the complete forebrain
were cut in a freezing microtome (Leica CM3050 S cryo-
stat, Leica, Wetzlar, Germany) and mounted on micro-
scope slides. The brain sections were fixed with 4 %
paraformaldehyde and stained with hematoxylin-eosin
using standard protocols. Damage including focal cor-
tical contusions was used as criteria for trauma severity;
all cases without focal lesions were classified as mild in-
juries (mTBI), cases with focal lesions as TBI.
μPET studies
The [18F]DPA-714-μPET scans were performed and eval-
uated in 15 mice on day 1, 28 mice on day 7, and 6 mice
on day 16 after TBI. A [18F]FDG-μPET scan was ac-
quired between days 2–5 after TBI in 28 mice. μPET
scans and image analysis were carried out using the
Inveon μPET scanner (Inveon®, Siemens Medical Solu-
tions, Knoxville, TN, USA). Mice were kept under 1.5 %
isoflurane anesthesia in 100 % oxygen during the whole
time between tracer injection and the end of the PET
scan. Their body temperature was maintained at physio-
logical level with a custom-made heating pad during the
procedure. The animals received an injection of 7.4 ±
4.6 MBq of [18F]DPA-714 or 5.8 ± 1.5 MBq of [18F]FDG
in a volume of 100-150 μL into the tail vein. In case of
[18F]FDG-μPET food was removed 4 h before injection,
water was available anytime. The mice were then placed
in prone position into the animal scanner bed to per-
form a 20 min μPET scan 40 min after [18F]DPA-714
administration and 10 min μPET scan 50 min after ad-
ministration of [18F]FDG, respectively.
The acquired 3D dataset was sorted with Fourier
rebinning (FORE) to a 2D dataset of sinograms, which
were reconstructed with the OSEM2D reconstruction al-
gorithm. We used the software AMIDE Medical Image
Data Examiner (Version 1.0.4) to quantify the radioactiv-
ity uptake into different regions of interest (ROI). For
the semi-quantitative analysis, PET images of each ani-
mal were manually co-registered and two spherical ROI
were defined and used as a template for all images of the
same animal. The first ROI was outlined into the region
with the highest [18F]DPA-714 uptake on day 7 after
TBI. In the case that no increase in [18F]DPA-714 uptake
was detectable on day 7 (e.g., in the sham group), the
ROIs were drawn in the same brain region as those of a
co-registered TBI mouse showing increased [18F]DPA-
714 uptake in the damaged brain tissue.
The second ROI was placed into the cerebellum,
which was used as a relative reference tissue. We choose
cerebellum as a relative reference area, since in our TBI
model diffuse cellular damage after weight drop involves
forebrain structures in both the ipsilateral and contralat-
eral cerebral hemispheres whereas hindbrain and cere-
bellum appear normal in standard histology. Moreover,
the cerebellum has been recently validated as a pseudo-
reference region for TSPO binding radiotracers in
Alzheimer patients [25] and in a mouse model of
Alzheimer’s disease for both TSPO ligands and [18F]FDG
PET [26]. It has also been used as internal reference for
assessment of brain metabolism with [18F]FDG PET in
rat models of focal TBI [27, 28]. To ensure, that cerebel-
lum can be defined as a reference region for our TBI
model, we calculated the mean standardized uptake
value (SUV) for the outlined ROI of cerebellum in all ex-
amined mice and performed a statistical evaluation ac-
cording to the differences in the cerebellar [18F]DPA-714
uptake between sham, mTBI, and TBI groups during all
time-points after trauma induction. As no statistically
significant differences were found between the three
groups, at any time point (p = 0.62), we concluded that
cerebellum can be considered as a stable reference re-
gion also in our model. Finally, the [18F]DPA-714 uptake
values of the region with the highest tracer uptake were
divided by the uptake values of the ROI of the cerebel-
lum and referred to as lesion-to-cerebellum ratio (L/C
ratio).
Ex vivo autoradiography and concomintant IBA-1
immunohistochemistry
Combined autoradiography and immunostaining for
IBA-1 was performed subsequent to the [18F]DPA-714-
μPET scan on day 7 in 5 sham-operated, 11 mTBI, and 6
TBI mice and on day 16 in 3 mTBI and 3 TBI mice.
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After the μPET-scans (60 min after injection of
[18F]DPA-714), the mice were sacrificed by CO2 inhal-
ation. Brains were harvested and immediately frozen in
methyl butane on dry ice. Coronal sections (18 μm) were
cut on microscope slides in a freezing microtome (Leica)
as described above. The sections were exposed on a
phosphor image plate (Biostep, Jahnsdorf, Germany)
overnight. The image plate was read out on a image
plate scanner (Dürr Medical, Bietigheim-Bissingen,
Germany). After imaging, the same sections were proc-
essed for IBA-1 immunohistochemistry as described
below.
For quantification, one circular ROI was placed in the
area of highest [18F]DPA-714 accumulation representing
the highest microglia activation and a second circular ROI
was drawn in the area of lowest [18F]DPA-714 uptake and
the lowest microglia activation. As the weight-drop
trauma generates a variable pattern of focal lesions and
diffuse axonal damage in both cortical hemispheres, the
regions of interest could not always be set in the same
position. To ensure the correct ROI position in the region
of the highest and lowest microglia activation, each auto-
radiography image was compared with the staining pat-
tern of IBA-1-labelled microglia on the same cryosection.
For semi-quantitative data analysis, [18F]DPA-714 uptake
values of the region with the highest microglia activation
were divided by the uptake values of the region with the
lowest microglia activation and referred to as TBI-to-
normal-tissue-ratio (TBI/N ratio). Data analysis and image
editing were performed with the software AMIDE Medical
Image Data Examiner (version 1.0.4) and Gimp (cersion
2.8.14), respectively.
In vitro autoradiography
In a separate study, mice (n = 15) were euthanized 7 days
after TBI and the brains removed for cryosectioning for
correlative assessment of [18F]DPA-714 uptake to histo-
logical damage and cellular reactions on adjacent brain
sections. Eighteen-micrometer cryosections were pre-
pared as described above and washed in PBS, dryed, and
subsequently incubated with 100 μL [18F]DPA-714
(13 MBq/mL) for 30 min at room temperature (RT).
Afterwards, the cryosections were washed three times in
PBS and finally shortly rinsed in deionized water. After
drying, the sections were exposed on a phosphor image
plate (Biostep, Jahnsdorf, Germany) for 30 min. The
image plate was read out on a image plate scanner (Dürr
Medical, Bietigheim-Bissingen, Germany).
Immunohistochemistry
The cryosections were fixed with 4 % paraformaldehyde
and subsequently washed in PBS, blocked with 10 %
normal horse serum (NHS) (Jackson Immuno Research,
Suffolk, UK) and 0.2 % Triton X. After a further washing
step with PBS, the tissue was incubated with primary
antibodies in PBS with 2 % NHS and 0.5 % Triton X for
2 days at 4 °C. The sections were washed in PBS and in-
cubated with biotinylated second antibodies in PBS with
2 % NHS and 0.5 % Triton X for 1 h at RT. After wash-
ing in PBS, sections were incubated with Avidin-Biotin
(Standard Ultra Sensitive ABC Staining Kit, Thermo
Scientific, Rockford, IL, USA) for 30 min at RT and sub-
sequently incubated for 4 min with 3,3′-diaminobenzidine
(DAB) or DAB with nickel enhancement for all IBA-1
stained sections. The reaction was stopped in water, and
the tissue was dehydrated using an increasing ethanol series
and xylol. Finally, the sections were mounted with cover-
slips using Vitro Clud (R. Langenbrinck, Emmendingen,
Germany) embedding medium. The following antibodies
were used: polyclonal rabbit anti-IBA-1 (1:5000, WAKO
Pure Chemical Industries, Neuss, Germany), monoclonal
mouse anti-glial fibrillary acidic protein (GFAP, 1:1000,
Novocastra, Newcastle upon Tyne, UK), and monoclonal
mouse anti-non-phosphorylated neurofilament H (SMI-32,
1:1000, Covance, Freiburg, Germany), biotinylated goat
anti-rabbit or horse anti-mouse IgGs (Vector Laboratories,
Burlingame, CA, USA).
Quantification of immunohistochemical staining
IBA-1 staining on the cryosections used first for ex vivo
[18F]DPA-714 autoradiography was assessed under a
light microscope (Olympus BH2, Olympus-Germany
GmbH, Hamburg, Germany) using an objective with
×40 magnification. Successful staining that could be
quantified was obtained in 22 mice on day 7 and in 5
mice on day 16. The numbers of IBA-1 positive micro-
glia were determined from four cortical fields in the ipsi-
lateral and contralateral hemispheres in four separate
brain sections per animal and expressed as mean cell
count/mm2 for each animal.
In a separate set of 15 mice used for in vitro autoradi-
ography, the number of GFAP-positive astrocytes and
SMI-32-positive retraction bulbs as a marker for dam-
aged axons [29–31] were counted in adjacent sections to
those used for [18F]DPA-714 autoradiography on day 7.
GFAP-positive astrocytes were counted on four cortical
fields in three separate brain sections per animal and
expressed as mean cell count/mm2. SMI-32-positive re-
traction bulbs were counted in both brain hemispheres
in three separate brain sections per animal and
expressed as mean counts/section for each animal.
Statistical analysis
The NSS scales are depicted as scatter plots, including
median with the 25 percentile and the 75 percentile
given in parentheses in the text. All other data are
expressed as mean ± standard deviation (SD). The statis-
tics were performed by using PrismGraph 5.0 software
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package (GraphPad Software, GraphPad Inc, La Jolla,
CA, USA). Data were tested for Gaussian distribution
and homogeneity of variance with the Kolmogorov-
Smirnov test and the Levene’s test, respectively. In case
of normal distribution and variance homogeneity (PET),
the statistical significance was tested by one-way analysis
of variance (ANOVA) with post hoc Bonferroni test.
Non-parametric data (NSS, autoradiography) were an-
alyzed using Kruskal-Wallis test with post hoc Dunn’s
correction. For linear regression analysis the Spearman’s
Rho rank correlation (rs) was calculated. p values < 0.05
were considered statistically significant.
Results
Radiochemistry
[18F]DPA-714 and [18F]FDG were prepared in-house at the
Interdisciplinary PET-center of the University Würzburg.
[18F]DPA-714 was obtained in 65–73 % radiochemical yield
and a specific activity of 78 ± 35 GBq/μmol using a Raytest
Synchrom module. [18F]FDG was obtained in 85–87 %
radiochemical yield following the GE Fastlab methodology,
as routinely prepared for clinical applications. Before use,
[18F]DPA-714 and [18F]FDG were analyzed by HPLC for
radiochemical purity and sterile filtered through a 0.22-μm
sterile filter. Radiochemical purity was ≥99 % for both
radiopharmaceuticals.
Functional outcome and lesion severity
Functional deficits on the neuroscore (NSS) in all TBI
mice were significantly worse than in sham-operated
mice over the first 24 h (Fig. 1). The initial NSS (median,
25 %, 75 % percentile) 1 h after trauma was 6 (5, 6, n =
10) in mice with focal lesions in postmortem histology;
in mTBI mice without such focal defects, it was 3 (3, 5,
n = 15) and in sham-operated mice 1 (1, 1, n = 7). On
day 1 after injury, the corresponding scores were 5.5 (5,
6, n = 10) in TBI, 3 (3, 4, n = 15) in mTBI, and 1 (1,
2, n = 7) in sham-operated mice. On day 7, NSS in TBI
mice (5, 4,25, 6, n = 8) was still significantly worse than in
mTBI mice (2, 1, 2, n = 9) or in sham-operated mice (1, 0,
1.5, n = 5) (Fig. 1). The presence of focal cortical damage
in postmortem histology correlated positively with the
severity of the functional deficit on NSS 1 h after trauma
(rs = 0.61, p = 0.001, n = 25), on day 1 (rs = 0.81, p < 0.0001,
n = 25), and on day 7 (rs = 0.73, p < 0.001, n = 17).
μPET-studies
TSPO ligand binding was determined by [18F]DPA-714
μPET on days 1, 7, and 16 and correlated to metabolic
imaging with [18F]FDG-μPET on day 2, 4, or 5 after TBI.
As shown in the representative images in Fig. 2a, brain
glucose uptake was globally reduced with a noticeable
focal deficit of [18F]FDG accumulation in the cortical
contusions on day 2 after TBI. Such deficits were not
visible in mTBI or sham-operated mice (Fig. 2a). Brain
uptake of [18F]DPA-714 in all mice was low on day 1
after TBI as illustrated in the representative images
(Fig. 2b). Accordingly, the semi-quantitative analysis of
the lesion-to-cerebellum (L/C) ratios on day 1 after TBI
revealed no differences in radiotracer uptake between
the sham-operated, mTBI, and TBI mice (Fig. 2b). On
days 7 and 16, after trauma [18F]DPA-714 uptake was
substantially increased only in cortical areas of low re-
gional glucose uptake in μPET on day 2 (see arrowheads
in the μPET images of Fig. 2). Brain [18F]DPA-714 up-
take in mTBI or sham-operated mice remained low on
das 7 (Fig. 2c). The semi-quantitative L/C ratios in TBI
mice with focal lesions were 2.6-fold (p < 0.001) higher
than in sham mice and 2.3-fold (p < 0.001) higher than
in mice with mild TBI on day 7 (Fig. 2e). Linear correl-
ation analysis between glucose metabolism and TSPO
ligand binding revealed a highly significant correlation
between [18F]FDG uptake on days 2, 4, and 5 and the
[18F]DPA-714 uptake on day 7 in individual mice
(Fig. 2f ). On day 16, after trauma [18F]DPA-714 uptake
into the focal contusions in TBI mice remained elevated
Fig. 1 Functional outcome of mice after closed head weight-drop TBI. Outcome was assessed by using the neurological severity score (NSS), a
composite score including tasks on motor function, alertness, and physiological behavior, with higher scores indicating worse deficit. Black squares
indicate sham-operated mice (n = 7 on 1 h and on day 1, n = 5 on day 7), gray triangles mTBI (n = 15 1 h and on day 1, n = 9 on day 7), and open
circles TBI mice (n = 10 1 h and on day 1, n = 8 on day 7), ***p < 0.001, **p < 0.01)
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(Fig. 2d). As only three animals in each group were
available for PET-analysis on day 16, these data are
shown as scatter plots of individual values with means in
Fig. 2d and no statistical analysis of these data is shown.
Ex vivo autoradiography and immunohistochemistry studies
Combined autoradiography and immunostaining was
successful on brain sections from 5 sham-operated mice,
11 mTBI, and 6 TBI mice on day 7 and on sections of 2
Fig. 2 [18F]FDG- and [18F]DPA-714-μPET imaging after closed head weight-drop TBI in mice. a Representative transverse images of [18F]FDG-μPET,
2 days after TBI show an area of no [18F]FDG uptake within the focal cortical lesion of a TBI mouse (white arrow head), in contrast to a uniform
[18F]FDG uptake in sham-operated and mTBI mice. b–d Representative transverse images of 18F]DPA-714-μPET on the left and semi-quantitative
analyses of these data on the right. Arrowheads in the μPET images in panels. c, d The visible overlap of [18F]DPA-714 uptake on days 7 and 16
with the reduction of the [18F]FDG uptake on day 2 (a). b [18F]DPA-714-μPET on day 1 after TBI shows no significant difference in [18F]DPA-714
uptake between sham (n = 5), mTBI (n = 12), and TBI (n = 8) mice. c [18F]DPA-714-μPET on day 7 after TBI. Compared to the sham animals (0.7 ±
0.2, mean ± SD, n = 6), the lesion-to-cerebellum (L/C) ratio was not significantly increased in mTBI mice (0.8 ± 0.3, n = 12), but it was significantly
increased in TBI mice (1.9 ± 0.5, n = 10) as compared to both sham and mTBI mice. d [18F]DPA-714-μPET on day 16 after TBI. The L/C ratio of three
mTBI and three TBI mice. e Time-course of the L/C ratio in the three groups (data identical to bar graphs in b–d. The L/C ratio of TBI mice
significantly increased from 0.61 on day 1 to 1.85 on day 7 as compared to both sham-operated and mTBI mice and the decreased to 1.38 on
day 16. In mTBI mice the L/C ratio was not statistically different from that in sham group even if it tended to increase from 0.67 on day 1 to 0.82
on day 16. f Linear regression analysis between [18F]FDG uptake on days 2–5 and [18F]DPA-714 accumulation on day 7 show a highly significant
correlation between reduced brain metabolic activity and [18F]DPA-714 uptake.***p < 0.001 in c and e
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mTBI mice and 3 TBI mice on day 16. In agreement
with the μPET findings, autoradiography performed after
μPET acquisition on day 7 and day 16 showed very low
[18F]DPA-714 uptake into brain tissue on day 7 in sham
and mTBI mice whereas in TBI mice with focal lesions
intense [18F]DPA-714 accumulation was detectable in
areas overlapping cortical lesions (Fig. 3a). In order to
visualize the cellular identity of structures binding
[18F]DPA-714, the brain sections exposed to ex vivo
autoradiography were additionally stained with the
microglia/monocyte marker IBA-1. As depicted in the
representative images in Fig. 3a, a light IBA-1 staining
Fig. 3 Combined ex vivo autoradiography and IBA-1 immunohistochemistry show increased [18F]DPA-714 uptake in microglia after closed head
weight-drop TBI in mice. a Representative images of [18F]DPA-714 autoradiography and IBA-1 immunohistochemical staining on the same section
of a sham, mTBI, and TBI mouse on day 7. The middle panel show merged images in each case. Red asterisks on the low magnification images
denote areas depicted in higher magnification below each image. Red arrows mark IBA-1 positive cells, scale bar = 50 μm. b Box-plots representing
calculated TBI/N ratios of [18F]DPA-714 binding in sham operated (n = 5), mTBI (n = 11), and TBI (n = 6) mice on day 7 and in c on day 16 in three mTBI
and three TBI mice. d IBA-1 positive cell counts on day 7 were derived from the sections used for calculation of the TBI/N ratios in b in sham (n = 5),
mTBI (n = 11), and TBI (n = 6) mice. e show IBA-1 counts on day 16 in two mTBI and three TBI mice used for TBI/N ratio in c. ***p < 0.001,
**p < 0.01, *p < 0.05
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was present in cells of microglial morphology in sham
mice. In mTBI mice, an intensified IBA-1 staining was
evident in microglia with enlarged cell body and pro-
cesses. In TBI mice with focal lesions, IBA-1 staining
was seen in activated microglia with mixed morphology
with the most intense staining in ameboid cells directly
overlapping the areas of intense [18F]DPA-714 binding
in autoradiography (Fig. 3a).
The TBI/N ratio analysis of the autoradiography images
showed in TBI mice with focal brain lesions an intense
[18F]DPA-714 accumulation on day 7 with a significantly
elevated mean TBI/N ratio of 12.8 ± 6.0 (mean ± SD, n =
11, p < 0.001) compared to sham (1.0 ± 0.02, n = 5) or
mTBI (1.9 ± 0.7, n = 6) (Fig. 3b). The median (25 %, 75 %
percentile) TBI/N ratio in the three TBI mice monitored
until day 16 was 9.8 (7.8, 13.7) and in the mTBI mice 1.5
(1.3, 1.9). As only three animals in each group were avail-
able for analysis on day 16 (Fig. 3c), no statistical analysis
of these data is shown.
Due to its higher sensitivity, avidin-biotin coupled sec-
ond antibodies and DAB-enhanced immunohistochemis-
try rather than immunofluorescent-labelled second
antibodies were used for visualization of the IBA-1 anti-
body staining [32]. In view of the high variability in
background staining inherent to this method, automated
image analysis of areas of IBA-1 immunopositive stain-
ing was not used to obtain quantitative estimates of the
cellular responses. Instead, we counted the number of
IBA-1 positive cells in four anatomically comparable
fields of both brain hemispheres in four individual brain
sections in each animal. As shown in Fig. 3d, counts of
IBA-1 positive cells on day 7 were higher than in sham-
operated mice in both mTBI (103 ± 27 cells/mm2, p < 0.05,
n = 11) and TBI (165 ± 26 cells/mm2, p < 0.001, n = 6) mice.
Highest cell counts were found in brain sections of
TBI mice with a strong [18F]DPA-714 binding in auto-
radiography on both days 7 and 16 (Fig. 3b–e).
Correlation of [18F]DPA-714 brain uptake with outcome
and IBA-positive cell counts
We used linear regression analysis to evaluate the correl-
ation of [18F]DPA-714 brain uptake with functional out-
come (NSS) and IBA-1 staining. As shown in Fig. 4) NSS
on day 7 correlated strongly with both the calculated L/C
ratio in μPET (Fig. 4a) and the TBI/N ratio in autoradiog-
raphy (Fig. 4b). Also, the cell counts of IBA-positive cells
on day 7 showed a strong correlation with both the L/C
Fig. 4 Correlation of [18F]DPA-714 brain uptake with outcome and IBA-positive cell counts after closed head weight-drop TBI in mice. Linear
regression analysis between NSS and L/C ratios of [18F]DPA-714 accumulation in μPET (a), between NSS and TBI/N ratios of [18F]DPA-714 accumulation
in ex vivo autoradiography (b), between IBA-1 counts and L/C ratios of [18F]DPA-714 (c), and between IBA-1 counts and TBI/N ratios of
[18F]DPA-714 (d)
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ratio in μPET (Fig. 4c) and with the TBI/N ratio in ex vivo
autoradiography (Fig. 4d).
Astrogliosis and diffuse axonal injury in relation to
[18F]DPA-714 binding
Additional immunohistochemical studies were performed
to evaluate astrocytic responses and axonal damage in
relation to functional outcome and [18F]DPA-714 binding
by in vitro autoradiography on day 7 after TBI in 3 sham-
operated mice, 6 mTBI, and 6 TBI mice (Fig. 5). In ac-
cordance with μPET and ex vivo autoradiography, a posi-
tive in vitro [18F]DPA-714 uptake was visible in the focal
TBI lesions in mice with high initial NSS (Fig. 5a). As








Fig. 5 Astrogliosis and diffuse axonal injury in relation to in vitro binding of [18F]DPA-714 on day 7 after closed head weight-drop TBI in mice. a
Representative images of [18F]DPA-714 in vitro autoradiography and the initial trauma severity (NSS at 1 h after TBI) plotted in relation to positive/
negative [18F]DPA-714 accumulation. b, c Representative images of GFAP-positive astrocytes (b) or SMI-32 staining of axons (c) on the left and on
the right counts of GFAP-positive cells or SMI-32 positive damaged axons (retraction bulbs/brain section) in sham-operated (n = 4), mTBI (n = 6),
and TBI (n = 6) mice. Scale bar = 50 μm. d, e Linear regression analyses between the initial trauma severity and number of GFAP-positive cells (d)
or SMI-32 positive retraction bulbs (e). f, g GFAP-positive cells counts (f) or damaged axons (g) plotted in relation to [18F]DPA-714 uptake in TBI
mice by in vitro autoradiography (negative n = 6, positive n = 6). ***p < 0.001, **p < 0.01, *p < 0.05
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was enhanced in all TBI mice and the number of GFAP-
positive cells correlated with NSS (Fig. 5d) and [18F]DPA-
714 uptake (Fig. 5f).
The established neuropathological marker for axonal
injury, SMI-32 [29, 31], identified strongly immunoposi-
tive axonal retraction bulbs in all TBI brains (Fig. 5c).
Both TBI mice with focal brain lesions and mTBI mice
with entirely diffuse damage showed damaged axons
throughout the brain hemispheres. Again, axonal dam-
age was worse in mice with more severe trauma and
positive [18F]DPA-714 uptake in autoradiography (Fig. 5c,
g). As expected [29], SMI-32 staining identified normal
axonal filaments in the brains of sham-operated mice
but no pathological staining of damaged axons (Fig. 5c).
The degree of axonal damage correlated strongly with
the initial severity of functional deficits (Fig. 5e).
Discussion
In this study, we used μPET imaging with the specific
TSPO ligand [18F]DPA-714 in a mouse closed head brain
trauma model and correlated it with functional and
histopathological trauma severity and reduced cerebral
glucose uptake. By combining μPET imaging with ex
vivo autoradiography and concomitant IBA-1 antibody
staining on the same brain sections, we were able to
identify activated microglia as the direct cellular correl-
ate of the increased [18F]DPA-714 uptake.
We used a weight-drop brain injury model to generate
a closed head injury in mice [20, 21, 23, 24]. The highly
variable combination of both focal cortical contusions
and diffuse axonal damage in this model reflects closely
the heterogeneity of human TBI [33, 34]. Identical to the
Glasgow Coma Scale in clinical TBI [35], outcome in
our mouse model can be monitored on a relatively sim-
ple functional scale which correlated with postmortem
histopathological analysis of trauma severity and in par-
ticular the presence of focal cortical lesions. Importantly,
a positive uptake of the TSPO-tracer and a measurable
deficit in glucose uptake in μPET were seen exclusively
in mice with worse functional outcome and more severe
trauma that included focal cortical damage.
The heterogeneous pattern of focal cortical contusions
and global diffuse axonal damage in our TBI model
made analysis of the imaging data challenging. Diffuse
trauma lesions extended to different brain regions and
so it was difficult to define an unaffected reference re-
gion. Furthermore, a truly genuine reference region with
no TSPO expression does not exist because of the ubi-
quitous glial expression pattern of TSPO in the brain
[8]. Cerebellum has been recently validated as a pseudo-
reference region for TSPO binding radiotracers in
Alzheimer patients [25] and in a mouse model of
Alzheimer’s disease [26]. It has also been used as in-
ternal reference for assessment of brain metabolism with
[18F]FDG PET in rat models of TBI [27, 28]. Assessment
of cerebellar [18F]DPA-714 uptake in calculated mean
SUVs for the outlined cerebellar ROIs in all mice was
used in the present study to confirm this brain region as
a relative reference region also in our model. Radiotracer
binding in cerebellum showed no differences between
the sham, mTBI, and TBI mice.
We used [18F]FDG-μPET to correlate TSPO ligand im-
aging to brain metabolism. Metabolic [18F]FDG imaging
has not been previously reported in a mouse TBI model,
but our findings match up with previous reports in rats
even if in these studies, TBI model, trauma severity, and
acquisition protocols and scan times [7] were different
than those in the present study. In agreement with our re-
sults, an early but sustained reduction of glucose uptake
in focally damaged brain areas is evident within the first
days after trauma in rat models of TBI [27, 28, 36–38]. In
our mouse study, reduced glucose metabolism was only
visible in animals with focal cortical lesions and more se-
vere trauma. In mice with solely diffuse axonal damage
and less severe functional outcome score [18F]FDG accu-
mulation was largely homogenous in the whole brain.
However, metabolic imaging in the present study was not
extended beyond day 5 and thus the late deterioration
seen in some recent studies after mTBI in rats [37] was
not captured in our study. Another limitation of the
present study is that due to technical reasons, [18F]FDG-
μPET imaging was not possible for all animals on one des-
ignated day but was performed on either on days 2, 4, or 5
after trauma. Therefore, a detailed analysis of the
[18F]FDG-μPET scans on each day was not possible. Thus,
the correlation analysis of [18F]FDG-μPET scans over 2–
5 days may be inferred solely as a metabolic correlate for
the consecutive [18F]DPA-714 imaging data on day 7.
Accumulation of [18F]DPA-714 by μPET was in-
creased in the focal lesions on days 7 and 16 after TBI.
In agreement with a previous study in rat TBI, no sig-
nificant tracer uptake could be detected acutely 24 h
after TBI [39]. Functional trauma severity strongly cor-
related with the increased [18F]DPA-714 accumulation
in μPET on day 7. Again, no clear tracer accumulation
could be detected at any time point in mice with mTBI,
even if a slightly rising trend of [18F]DPA-714 uptake
until day 16 was apparent. In a previous study [39] in
rats, lesion to normal ratios of [18F]DPA-714 were in-
creased as early as 2 days after controlled cortical im-
pact injury. However, similar to our data, the ratios
peaked around day 6 and then gradually decreased to
nearly normal levels on day 28 [39]. In mouse models
of ischemic stroke, temporal pattern of [18F]DPA-714
binding in μPET peaked around 10–14 days after stroke
[11, 40] and a prominent binding of the radiotracer
within the ischemic lesions persisted up to 16 days after
the ischemic insult [40].
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Ex vivo autoradiography subsequent to [18F]DPA-714-
μPET imaging confirmed the in vivo μPET findings and
showed a significant increase of TSPO ligand binding on
days 7 and 16 after TBI. For quantitative analysis, the im-
ages of ex vivo autoradiography were aligned with IBA-1
stained brain sections. This permitted the identification of
microglia as the [18F]DPA-714 binding cellular structures.
The increased counts of IBA-1 positive microglia corre-
lated strongly with the increased [18F]DPA-714 binding in
ex vivo autoradiography. These data are in agreement with
results of previous autoradiography studies in rats show-
ing increased TSPO ligand binding and microglia activa-
tion by staining on adjacent brain sections 1 week after
TBI [14, 39, 41, 42]. Similar findings have been reported
after ischemic stroke in mice as [18F]DPA-714 binding
strongly co-localized with IBA-1 positive microglia on ad-
jacent brain sections 14 days after ischemic stroke [43].
An in vitro autoradiography study using [3H]PK11195 and
a closed head weight-drop TBI model similar to ours
[23, 44] also found a significant increase in TSPO ligand
binding in the contusioned brain areas 7 days after TBI
[44] though the radiotracer binding was not confirmed
with a correlative immunohistochemical analysis. Thus,
our study is the first to directly identify microglia as the
cellular correlate of [18F] DPA-714 binding by combined
in vivo μPET, ex vivo autoradiography, and IBA-1 immu-
nohistochemistry in a mouse model of closed head injury.
Morphological activation and increased cell counts of
IBA-1 positive cells were detected by immunohisto-
chemistry also after mTBI indicating that this method is
more sensitive than [18F]DPA-714 autoradiography to
identify microglia activation at cellular level. The tem-
poral pattern of microglia responses in our study
matches those reported for trauma-induced expression
of M1 phenotype of microglia in rats [30]. In this previ-
ous study, the cell counts of M1 microglia (IBA1+/CD16+)
in the contusioned brain tissue peaked 7 days after a con-
trolled cortical impact injury and the expression level
remained elevated over 14 days. In contrast, the expression
of M2 microglia (IBA-1+/CD206+) showed a peak at 5 days
and then declined to control levels by day 14 [30]. Activated
microglia, identified morphologically by swollen cell bodies
and thicker, shrunken processes, were also shown to be the
main cellular correlates of sustained TSPO expression
in injured brain tissue after a fluid percussion injury
in rats [42].
Even if activation of microglia plays an important role in
the pathophysiology of TBI [30], damage and cellular re-
sponses are not restricted to one cellular substrate but in-
clude a plethora of complex pathologies including diffuse
axonal injury and astrogliosis [33]. As expected, astrogliosis
and diffuse axonal injury were clearly detectable after TBI
also in our mice model and these cellular reactions corre-
lated with functional outcome and trauma severity. Positive
brain [18F]DPA-714 uptake in autoradiography also corre-
lated with astrocyte activation and the extent of axonal in-
jury even if the pattern of the [18F]DPA-714 signal in
autoradiography did not entirely overlap the more diffuse
areas of axonal damage and increased GFAP staining.
Nevertheless, [18F]DPA-714 binding to activated astrocytes
[39] cannot be excluded, even if upregulation of TSPO ex-
pression after TBI has been shown to be more prominent
in microglia than in astroglial cells [14, 41, 42, 45].
Conclusions
[18F] DPA-714 uptake in μPET/autoradiography corre-
lated with trauma severity, brain metabolic deficits, and
microglia activation after closed head TBI.
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